MedPath

Multivisceral Resections for Locally Advanced Gastric Cancer

Completed
Conditions
Gastric Cancer
Registration Number
NCT06103435
Lead Sponsor
Jagiellonian University
Brief Summary

The goal of this observational study is to assess whether the postoperative course and survival of patients subject to multivisceral resections for locally advanced gastric cancer (cT4b) were affected by the extent of surgery. An electronic database of 1476 patients with non-metastatic gastric cancer treated between January 1996 and December 2020 will be reviewed. The main questions it aims to answer are:

* Does splenectomy, distal pancreatectomy or partial colectomy affect postoperative complications

* What factors affect prognosis of patients with locally advanced gastric cancer

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1476
Inclusion Criteria
  • gastric adenocarcinoma
  • intraoperatively suspected infiltration of surrounding organs (stage cT4bN0-3bM0)
  • partial or total gastrectomy
Exclusion Criteria
  • distant metastases (M1)
  • gastrectomy combined with resection of organs other than spleen, pancreas, or colon

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Complicationsup to 90 days

Type and severity of complications graded by Clavien-Dindo scoring system (from 0 to 5, higher scores mean worse outcome)

SurvivalOverall survival from surgery to death or last follow up, whichever came first, assessed up to 60 months

Overall survival

Secondary Outcome Measures
NameTimeMethod
Rate of readmissionsOne year from surgery

Readmission

Length of postoperative hospital stayUp to 6 months

Hospital stay

Rate of reoperationsup to 90 days

Reoperations

Trial Locations

Locations (1)

First Department of Surgery, Jagiellonian University Medical College

🇵🇱

Kraków, Małopolska, Poland

© Copyright 2025. All Rights Reserved by MedPath